{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:28:47Z","timestamp":1792106927714,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Hebei Provincial Specialty Capacity Building and Specialty Leader Training Project","award":["[2018]674"],"award-info":[{"award-number":["[2018]674"]}]},{"name":"the Hebei Provincial Specialty Capacity Building and Specialty Leader Training Project","award":["[2018]674"],"award-info":[{"award-number":["[2018]674"]}]},{"name":"the Hebei Provincial Specialty Capacity Building and Specialty Leader Training Project","award":["[2018]674"],"award-info":[{"award-number":["[2018]674"]}]},{"name":"the Hebei Provincial Specialty Capacity Building and Specialty Leader Training Project","award":["[2018]674"],"award-info":[{"award-number":["[2018]674"]}]},{"name":"the Hebei Provincial Specialty Capacity Building and Specialty Leader Training Project","award":["[2018]674"],"award-info":[{"award-number":["[2018]674"]}]},{"name":"the Hebei Provincial Specialty Capacity Building and Specialty Leader Training Project","award":["[2018]674"],"award-info":[{"award-number":["[2018]674"]}]},{"name":"the Hebei Provincial Excellent Talents in Clinical Medicine Training Project","award":["[2019]139"],"award-info":[{"award-number":["[2019]139"]}]},{"name":"the Hebei Provincial Excellent Talents in Clinical Medicine Training Project","award":["[2019]139"],"award-info":[{"award-number":["[2019]139"]}]},{"name":"the Hebei Provincial Excellent Talents in Clinical Medicine Training Project","award":["[2019]139"],"award-info":[{"award-number":["[2019]139"]}]},{"name":"the Hebei Provincial Excellent Talents in Clinical Medicine Training Project","award":["[2019]139"],"award-info":[{"award-number":["[2019]139"]}]},{"name":"the Hebei Provincial Excellent Talents in Clinical Medicine Training Project","award":["[2019]139"],"award-info":[{"award-number":["[2019]139"]}]},{"name":"the Hebei Provincial Excellent Talents in Clinical Medicine Training Project","award":["[2019]139"],"award-info":[{"award-number":["[2019]139"]}]},{"name":"the Hebei province medical technology tracking project","award":["GZ2020013"],"award-info":[{"award-number":["GZ2020013"]}]},{"name":"the Hebei province medical technology tracking project","award":["GZ2020013"],"award-info":[{"award-number":["GZ2020013"]}]},{"name":"the Hebei province medical technology tracking project","award":["GZ2020013"],"award-info":[{"award-number":["GZ2020013"]}]},{"name":"the Hebei province medical technology tracking project","award":["GZ2020013"],"award-info":[{"award-number":["GZ2020013"]}]},{"name":"the Hebei province medical technology tracking project","award":["GZ2020013"],"award-info":[{"award-number":["GZ2020013"]}]},{"name":"the Hebei province medical technology tracking project","award":["GZ2020013"],"award-info":[{"award-number":["GZ2020013"]}]},{"name":"the Hebei Clinical Medical Research Centre Project","award":["20577701D"],"award-info":[{"award-number":["20577701D"]}]},{"name":"the Hebei Clinical Medical Research Centre Project","award":["20577701D"],"award-info":[{"award-number":["20577701D"]}]},{"name":"the Hebei Clinical Medical Research Centre Project","award":["20577701D"],"award-info":[{"award-number":["20577701D"]}]},{"name":"the Hebei Clinical Medical Research Centre Project","award":["20577701D"],"award-info":[{"award-number":["20577701D"]}]},{"name":"the Hebei Clinical Medical Research Centre Project","award":["20577701D"],"award-info":[{"award-number":["20577701D"]}]},{"name":"the Hebei Clinical Medical Research Centre Project","award":["20577701D"],"award-info":[{"award-number":["20577701D"]}]},{"name":"the project of the Hebei Provincial Excellent Health Talents and High-Quality Development of Public Hospitals","award":["[2022]180"],"award-info":[{"award-number":["[2022]180"]}]},{"name":"the project of the Hebei Provincial Excellent Health Talents and High-Quality Development of Public Hospitals","award":["[2022]180"],"award-info":[{"award-number":["[2022]180"]}]},{"name":"the project of the Hebei Provincial Excellent Health Talents and High-Quality Development of Public Hospitals","award":["[2022]180"],"award-info":[{"award-number":["[2022]180"]}]},{"name":"the project of the Hebei Provincial Excellent Health Talents and High-Quality Development of Public Hospitals","award":["[2022]180"],"award-info":[{"award-number":["[2022]180"]}]},{"name":"the project of the Hebei Provincial Excellent Health Talents and High-Quality Development of Public Hospitals","award":["[2022]180"],"award-info":[{"award-number":["[2022]180"]}]},{"name":"the project of the Hebei Provincial Excellent Health Talents and High-Quality Development of Public Hospitals","award":["[2022]180"],"award-info":[{"award-number":["[2022]180"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Up to now, there is no unequivocal intervention to mitigate vascular calcification (VC) in patients with hemodialysis. This network meta-analysis aimed to systematically evaluate the clinical efficacy of sodium thiosulfate, bisphosphonates, and cinacalcet in treating vascular calcification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A comprehensive study search was performed using PubMed, Web of Science, the Cochrane Library, EMBASE and China National Knowledge Internet (CNKI) to collect randomized controlled trials (RCTs) of sodium thiosulfate, bisphosphonates, and cinacalcet for vascular calcification among hemodialysis patients. Then, network meta-analysis was conducted using Stata 17.0 software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, eleven RCTs including 1083 patients were qualified for this meta-analysis. We found that cinacalcet (SMD \u2212\u20090.59; 95% CI [\u20130.95, -0.24]) had significant benefit on vascular calcification compared with conventional therapy, while sodium thiosulfate or bisphosphonates did not show such efficiency. Furthermore, as for ranking the efficacy assessment, cinacalcet possessed the highest surface under the cumulative ranking curve (SUCRA) value (88.5%) of lessening vascular calcification and was superior to sodium thiosulfate (50.4%) and bisphosphonates (55.4%). Thus, above results suggested that cinacalcet might be the most promising drug for vascular calcification treatment in hemodialysis patients. Mechanistically, our findings illustrated that cinacalcet reduced serum calcium (SMD \u2212\u20091.20; 95% CI [\u20132.08, \u2212\u20090.33]) and showed the tendency in maintaining the balance of intact Parathyroid Hormone (iPTH) level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This network meta-analysis indicated that cinacalcet appear to be more effective than sodium thiosulfate and bisphosphonates in mitigating vascular calcification through decreasing serum calcium and iPTH. And cinacalcet might be a reasonable option for hemodialysis patients with VC in clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic Review Registration<\/jats:title>\n                <jats:p>[<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.crd.york.ac.uk\/PROSPERO\">http:\/\/www.crd.york.ac.uk\/PROSPERO<\/jats:ext-link>], identifier [CRD42022379965].<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-024-03460-x","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T13:02:53Z","timestamp":1705928573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparative efficacy of sodium thiosulfate, bisphosphonates, and cinacalcet for the treatment of vascular calcification in patients with haemodialysis: a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Lei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"issue":"6","key":"3460_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/jamacardio.2017.0363","volume":"2","author":"J Chen","year":"2017","unstructured":"Chen J, et al. Coronary artery calcification and risk of Cardiovascular Disease and Death among patients with chronic kidney disease. JAMA Cardiol. 2017;2(6):635\u201343.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"3460_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12325-021-01927-z","volume":"39","author":"M Evans","year":"2022","unstructured":"Evans M, et al. A narrative review of chronic kidney disease in clinical practice: current challenges and Future perspectives. Adv Ther. 2022;39(1):33\u201343.","journal-title":"Adv Ther"},{"issue":"14","key":"3460_CR3","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","volume":"74","author":"MJ Sarnak","year":"2019","unstructured":"Sarnak MJ, et al. Chronic kidney Disease and Coronary Artery Disease: JACC State-of-the-art review. J Am Coll Cardiol. 2019;74(14):1823\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3460_CR4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11033-020-06086-y","volume":"48","author":"A Singh","year":"2021","unstructured":"Singh A, Tandon S, Tandon C. An update on vascular calcification and potential therapeutics. Mol Biol Rep. 2021;48(1):887\u201396.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"3460_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00109-021-02037-7","volume":"99","author":"P D\u00fcsing","year":"2021","unstructured":"D\u00fcsing P, et al. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches. J Mol Med (Berl). 2021;99(3):335\u201348.","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"3460_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jbmr.4203","volume":"36","author":"ML Mace","year":"2021","unstructured":"Mace ML, et al. Chronic kidney Disease-Induced Vascular Calcification impairs bone metabolism. J Bone Miner Res. 2021;36(3):510\u201322.","journal-title":"J Bone Miner Res"},{"key":"3460_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2018.08.046","volume":"278","author":"AB Reiss","year":"2018","unstructured":"Reiss AB, et al. CKD, arterial calcification, atherosclerosis and bone health: inter-relationships and controversies. Atherosclerosis. 2018;278:49\u201359.","journal-title":"Atherosclerosis"},{"issue":"1","key":"3460_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1568010053622939","volume":"4","author":"KG Karageuzyan","year":"2005","unstructured":"Karageuzyan KG. Oxidative stress in the molecular mechanism of pathogenesis at different diseased states of organism in clinics and experiment. Curr Drug Targets Inflamm Allergy. 2005;4(1):85\u201398.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"4","key":"3460_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s11255-004-8786-y","volume":"36","author":"H Yatzidis","year":"2004","unstructured":"Yatzidis H. Absence or decreased endogenous thiosulfaturia: a cause of recurrent calcium nephrolithiasis. Int Urol Nephrol. 2004;36(4):587\u20139.","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"3460_CR10","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/ndt\/gfp755","volume":"25","author":"S Adirekkiat","year":"2010","unstructured":"Adirekkiat S, et al. Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients. Nephrol Dial Transplant. 2010;25(6):1923\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"3460_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/0004563218759371","volume":"55","author":"JS Kenkre","year":"2018","unstructured":"Kenkre JS, Bassett J. The bone remodelling cycle. Ann Clin Biochem. 2018;55(3):308\u201327.","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"3460_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1526-0968.2004.00136.x","volume":"8","author":"H Hashiba","year":"2004","unstructured":"Hashiba H, et al. Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients. Ther Apher Dial. 2004;8(3):241\u20137.","journal-title":"Ther Apher Dial"},{"issue":"1","key":"3460_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2215\/CJN.02550508","volume":"4","author":"ND Toussaint","year":"2009","unstructured":"Toussaint ND, Elder GJ, Kerr PG. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Clin J Am Soc Nephrol. 2009;4(1):221\u201333.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"3460_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/sdi.12710","volume":"31","author":"I Ruderman","year":"2018","unstructured":"Ruderman I, et al. Current and potential therapeutic strategies for the management of vascular calcification in patients with chronic kidney disease including those on dialysis. Semin Dial. 2018;31(5):487\u201399.","journal-title":"Semin Dial"},{"issue":"4","key":"3460_CR15","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","volume":"26","author":"P Raggi","year":"2011","unstructured":"Raggi P, et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. 2011;26(4):1327\u201339.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"3460_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"issue":"48","key":"3460_CR17","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1093\/eurheartj\/ehaa650","volume":"41","author":"AS Levey","year":"2020","unstructured":"Levey AS, et al. Nomenclature for kidney function and disease-executive summary and glossary from a kidney disease: improving global outcomes (KDIGO) consensus conference. Eur Heart J. 2020;41(48):4592\u20138.","journal-title":"Eur Heart J"},{"issue":"9","key":"3460_CR18","first-page":"1285","volume":"38","author":"ZR Yang","year":"2017","unstructured":"Yang ZR, Sun F, Zhan SY. Risk on bias assessment: (2) revised Cochrane risk of bias tool for individually randomized, parallel group trials (RoB2.0). Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38(9):1285\u201391.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"4","key":"3460_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/jrsm.1085","volume":"4","author":"S Donegan","year":"2013","unstructured":"Donegan S, et al. Assessing key assumptions of network meta-analysis: a review of methods. Res Synth Methods. 2013;4(4):291\u2013323.","journal-title":"Res Synth Methods"},{"key":"3460_CR20","unstructured":"Hedges L. and I. Olkin."},{"issue":"7414","key":"3460_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"2","key":"3460_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1037","volume":"3","author":"G Salanti","year":"2012","unstructured":"Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80\u201397.","journal-title":"Res Synth Methods"},{"issue":"3","key":"3460_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0962280207080643","volume":"17","author":"G Salanti","year":"2008","unstructured":"Salanti G, et al. Evaluation of networks of randomized trials. Stat Methods Med Res. 2008;17(3):279\u2013301.","journal-title":"Stat Methods Med Res"},{"key":"3460_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","volume":"15","author":"G R\u00fccker","year":"2015","unstructured":"R\u00fccker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15:58.","journal-title":"BMC Med Res Methodol"},{"key":"3460_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2288-12-150","volume":"12","author":"L Trinquart","year":"2012","unstructured":"Trinquart L, Chatellier G, Ravaud P. Adjustment for reporting bias in network meta-analysis of antidepressant trials. BMC Med Res Methodol. 2012;12:150.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"3460_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/ndt\/gfz204","volume":"35","author":"P Djuric","year":"2020","unstructured":"Djuric P, et al. Sodium thiosulphate and progression of vascular calcification in end-stage renal disease patients: a double-blind, randomized, placebo-controlled study. Nephrol Dial Transplant. 2020;35(1):162\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"3460_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000488009","volume":"139","author":"D Saengpanit","year":"2018","unstructured":"Saengpanit D, et al. Effect of Sodium Thiosulfate on arterial stiffness in end-stage renal disease patients undergoing chronic hemodialysis (Sodium Thiosulfate-Hemodialysis Study): a Randomized Controlled Trial. Nephron. 2018;139(3):219\u201327.","journal-title":"Nephron"},{"issue":"46","key":"3460_CR28","first-page":"3724","volume":"96","author":"Y Yu","year":"2016","unstructured":"Yu Y, et al. [Effect of sodium thiosulfate on coronary artery calcification in maintenance hemodialysis patients]. Zhonghua Yi Xue Za Zhi. 2016;96(46):3724\u20138.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"3460_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1744-9987.2006.00345.x","volume":"10","author":"H Hashiba","year":"2006","unstructured":"Hashiba H, et al. Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects. Ther Apher Dial. 2006;10(1):59\u201364.","journal-title":"Ther Apher Dial"},{"issue":"4","key":"3460_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2165\/00044011-200626040-00006","volume":"26","author":"T Ariyoshi","year":"2006","unstructured":"Ariyoshi T, et al. Effect of etidronic acid on arterial calcification in dialysis patients. Clin Drug Investig. 2006;26(4):215\u201322.","journal-title":"Clin Drug Investig"},{"issue":"6","key":"3460_CR31","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2215\/CJN.01040308","volume":"3","author":"S Fishbane","year":"2008","unstructured":"Fishbane S, et al. Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results. Clin J Am Soc Nephrol. 2008;3(6):1718\u201325.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"3460_CR32","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/ndt\/gfs568","volume":"28","author":"P Ure\u00f1a-Torres","year":"2013","unstructured":"Ure\u00f1a-Torres P, et al. Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism. Nephrol Dial Transplant. 2013;28(5):1241\u201354.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"3460_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12882-021-02312-2","volume":"22","author":"H Eddington","year":"2021","unstructured":"Eddington H, et al. A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism. BMC Nephrol. 2021;22(1):106.","journal-title":"BMC Nephrol"},{"issue":"1","key":"3460_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/0886022X.2018.1562356","volume":"41","author":"P Susantitaphong","year":"2019","unstructured":"Susantitaphong P, et al. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism. Ren Fail. 2019;41(1):326\u201333.","journal-title":"Ren Fail"},{"issue":"5","key":"3460_CR35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1124\/mol.115.098392","volume":"88","author":"ST Alexander","year":"2015","unstructured":"Alexander ST, et al. Critical cysteine residues in both the calcium-sensing receptor and the Allosteric activator AMG 416 underlie the mechanism of action. Mol Pharmacol. 2015;88(5):853\u201365.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"3460_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","volume":"15","author":"FM Hannan","year":"2018","unstructured":"Hannan FM, et al. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat Rev Endocrinol. 2018;15(1):33\u201351.","journal-title":"Nat Rev Endocrinol"},{"key":"3460_CR37","first-page":"25","volume":"7","author":"K Nakayama","year":"2013","unstructured":"Nakayama K, et al. Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism. Int J Nephrol Renovasc Dis. 2013;7:25\u201333.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"11","key":"3460_CR38","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/aps.2016.83","volume":"37","author":"M Wu","year":"2016","unstructured":"Wu M, et al. Cinacalcet ameliorates aortic calcification in uremic rats via suppression of endothelial-to-mesenchymal transition. Acta Pharmacol Sin. 2016;37(11):1423\u201331.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"3460_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000323550","volume":"33","author":"SJ Mathews","year":"2011","unstructured":"Mathews SJ, et al. Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy. Am J Nephrol. 2011;33(2):131\u20138.","journal-title":"Am J Nephrol"},{"key":"3460_CR40","first-page":"p9035193","volume":"2017","author":"NC Chen","year":"2017","unstructured":"Chen NC, Hsu CY, Chen CL. The strategy to prevent and regress the vascular calcification in Dialysis patients. Biomed Res Int. 2017;2017:p9035193.","journal-title":"Biomed Res Int"},{"issue":"1","key":"3460_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/j.ajkd.2009.12.039","volume":"56","author":"ND Toussaint","year":"2010","unstructured":"Toussaint ND, et al. Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis. 2010;56(1):57\u201368.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"3460_CR42","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ki.2012.425","volume":"83","author":"DC Wheeler","year":"2013","unstructured":"Wheeler DC, Becker GJ. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney Int. 2013;83(3):377\u201383.","journal-title":"Kidney Int"},{"issue":"2","key":"3460_CR43","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1124\/jpet.103.057273","volume":"308","author":"EF Nemeth","year":"2004","unstructured":"Nemeth EF, et al. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther. 2004;308(2):627\u201335.","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"3460_CR44","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.bone.2009.03.653","volume":"45","author":"N Joki","year":"2009","unstructured":"Joki N, et al. Effects of calcimimetic on vascular calcification and atherosclerosis in uremic mice. Bone. 2009;45(Suppl 1):S30\u20134.","journal-title":"Bone"},{"issue":"10","key":"3460_CR45","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/ki.2008.407","volume":"74","author":"T Kawata","year":"2008","unstructured":"Kawata T, et al. Cinacalcet suppresses calcification of the aorta and heart in uremic rats. Kidney Int. 2008;74(10):1270\u20137.","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"3460_CR46","first-page":"S34","volume":"12","author":"Y Tsuruta","year":"2008","unstructured":"Tsuruta Y, et al. Change in coronary artery calcification score due to cinacalcet hydrochloride administration. Ther Apher Dial. 2008;12(Suppl 1):S34\u20137.","journal-title":"Ther Apher Dial"},{"issue":"11","key":"3460_CR47","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s11255-019-02271-6","volume":"51","author":"J Xu","year":"2019","unstructured":"Xu J, et al. Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials. Int Urol Nephrol. 2019;51(11):2027\u201336.","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"3460_CR48","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1053\/j.ajkd.2004.08.029","volume":"44","author":"RZ Harris","year":"2004","unstructured":"Harris RZ, et al. Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200\u00a0mg once daily. Am J Kidney Dis. 2004;44(6):1070\u20136.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3460_CR49","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","volume":"68","author":"J Cunningham","year":"2005","unstructured":"Cunningham J, et al. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int. 2005;68(4):1793\u2013800.","journal-title":"Kidney Int"},{"issue":"5","key":"3460_CR50","doi-asserted-by":"publisher","first-page":"800","DOI":"10.2215\/CJN.10221014","volume":"10","author":"J Floege","year":"2015","unstructured":"Floege J, et al. The Effect of Cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: the EVOLVE Trial. Clin J Am Soc Nephrol. 2015;10(5):800\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"3460_CR51","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/ASN.2014040414","volume":"26","author":"SM Moe","year":"2015","unstructured":"Moe SM, et al. Effects of Cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE Trial. J Am Soc Nephrol. 2015;26(6):1466\u201375.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3460_CR52","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2215\/CJN.07730814","volume":"10","author":"PS Parfrey","year":"2015","unstructured":"Parfrey PS, et al. The effects of Cinacalcet in older and younger patients on Hemodialysis: the evaluation of Cinacalcet HCl therapy to Lower Cardiovascular events (EVOLVE) trial. Clin J Am Soc Nephrol. 2015;10(5):791\u20139.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03460-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03460-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03460-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T15:05:43Z","timestamp":1705935943000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03460-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3460"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03460-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}